BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

757 related articles for article (PubMed ID: 2420910)

  • 1. Action of antithymocyte globulin on normal human erythroid progenitor cell proliferation in vitro: erythropoietic growth-enhancing factors are released from marrow accessory cells.
    Mangan KF; D'Alessandro L; Mullaney MT
    J Lab Clin Med; 1986 Apr; 107(4):353-64. PubMed ID: 2420910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D; Strife A; Atzpodien J; Clarkson BD
    Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of three accessory cell populations in human bone marrow with erythroid burst-promoting properties.
    Linch DC; Lipton JM; Nathan DG
    J Clin Invest; 1985 Apr; 75(4):1278-84. PubMed ID: 3872887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of normal human erythropoiesis by human recombinant DNA-produced alpha-2-interferon in vitro.
    Mamus SW; Oken MM; Zanjani ED
    Exp Hematol; 1986 Dec; 14(11):1015-22. PubMed ID: 3780887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effects of purified recombinant human and murine B cell growth factor-1/IL-4 on colony formation in vitro by hematopoietic progenitor cells. Multiple actions.
    Broxmeyer HE; Lu L; Cooper S; Tushinski R; Mochizuki D; Rubin BY; Gillis S; Williams DE
    J Immunol; 1988 Dec; 141(11):3852-62. PubMed ID: 3053902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulatory effect of human insulin on erythroid progenitors (CFU-E and BFU-E) in human CD34+ separated bone marrow cells and the relationship between insulin and erythropoietin.
    Aoki I; Taniyama M; Toyama K; Homori M; Ishikawa K
    Stem Cells; 1994 May; 12(3):329-38. PubMed ID: 7521243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of deoxycytidine on 2-chloro-deoxyadenosine-mediated growth inhibition of normal human erythroid and myeloid progenitor cells.
    Bilgeri R; Petzer AL; Zilian U; Geisen FH; Schirmer M; Haun M; Konwalinka G
    Exp Hematol; 1993 Mar; 21(3):432-7. PubMed ID: 8095026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dependence of highly enriched human bone marrow progenitors on hemopoietic growth factors and their response to recombinant erythropoietin.
    Sieff CA; Emerson SG; Mufson A; Gesner TG; Nathan DG
    J Clin Invest; 1986 Jan; 77(1):74-81. PubMed ID: 3511093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thy-1 is a differentiation antigen that characterizes immature murine erythroid and myeloid hematopoietic progenitors.
    Miller BA; Lipton JM; Linch DC; Burakoff SJ; Nathan DG
    J Cell Physiol; 1985 Apr; 123(1):25-32. PubMed ID: 2857726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of recombinant human interleukin 3, granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor on human BFU-e in serum-free cultures.
    Misago M; Chiba S; Kikuchi M; Tsukada J; Sato T; Oda S; Eto S
    Int J Cell Cloning; 1989 Jan; 7(1):39-49. PubMed ID: 2465360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-lymphocyte-derived burst-promoting activity is a pleiotropic erythroid colony-stimulating factor, E-CSF.
    Feldman L; Frazier JG; Sytkowski AJ
    Exp Hematol; 1992 Nov; 20(10):1223-8. PubMed ID: 1426102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V; Ferguson KF; Heller G; Kernan NA
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of transforming growth factor beta 3 on the growth of highly enriched hematopoietic progenitor cells derived from normal human bone marrow and peripheral blood.
    Strife A; Lambek C; Perez A; Darzynkiewicz Z; Skierski J; Gulati S; Haley JD; ten Dijke P; Iwata KK; Clarkson BD
    Cancer Res; 1991 Sep; 51(18):4828-36. PubMed ID: 1893375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressive biological activity of a synthetic pentapeptide on highly enriched human and murine marrow hematopoietic progenitors: synergism with recombinant human tumor necrosis factor-alpha and interferon-gamma.
    Lu L; Foa P; Chillemi F; Shen RN; Lin ZH; Carow C; Broxmeyer HE
    Exp Hematol; 1989 Oct; 17(9):935-41. PubMed ID: 2506072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of erythropoiesis and myelopoiesis by exogenous erythropoietin in human long-term marrow cultures.
    Mayani H; Guilbert LJ; Janowska-Wieczorek A
    Exp Hematol; 1990 Mar; 18(3):174-9. PubMed ID: 2303109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence in vitro of IL-3/Epo fusion proteins compared with the combination of IL-3 plus Epo in enhancing the proliferation of single isolated erythroid and multipotential progenitor cells from human umbilical cord blood and adult bone marrow.
    Lu L; Xiao M; Li ZH; Jolliffe LK; Jones S; Broxmeyer HE; Weich N
    Exp Hematol; 1995 Sep; 23(10):1130-4. PubMed ID: 7656932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the human erythroid progenitor cells responsive to the erythropoietic-enhancing activity found in normal human serum.
    Mouchiroud G; Blanchet JP
    Int J Cell Cloning; 1987 Nov; 5(6):492-503. PubMed ID: 3429934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of the in vitro effects of testosterone and erythropoietin on Cfu-E and Bfu-E proliferation by pretreatment of the donor rats with cyproterone and flutamide.
    Malgor LA; Valsecia M; Vergés E; De Markowsky EE
    Acta Physiol Pharmacol Ther Latinoam; 1998; 48(2):99-105. PubMed ID: 9695882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of IL-1 alpha and -1 beta on the survival of human bone marrow cells responding to hematopoietic colony-stimulating factors.
    Hangoc G; Williams DE; Falkenburg JH; Broxmeyer HE
    J Immunol; 1989 Jun; 142(12):4329-34. PubMed ID: 2656864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.